These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8460973)

  • 41. [Chronic lymphocytic leukemia].
    Genet P; Sutton L
    Rev Prat; 2006 Feb; 56(4):439-43. PubMed ID: 16629094
    [No Abstract]   [Full Text] [Related]  

  • 42. Childhood leukemia.
    Hutter JJ
    Pediatr Rev; 2010 Jun; 31(6):234-41. PubMed ID: 20516235
    [No Abstract]   [Full Text] [Related]  

  • 43. Chronic lymphoproliferative disorders.
    Montserrat E; Binet JL; Dighiero G; Gale RP; Juliusson G; Keating M; Rai KR
    Rev Invest Clin; 1994 Apr; Suppl():52-8. PubMed ID: 7886310
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study.
    Apelgren P; Hasselblom S; Werlenius O; Nilsson-Ehle H; Andersson PO;
    Leuk Lymphoma; 2006 Dec; 47(12):2505-16. PubMed ID: 17169795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression.
    Barcellini W; Imperiali FG; Zaninoni A; Reda G; Consonni D; Fattizzo B; Lonati S; Nobili L; Zanella A; Cortelezzi A
    Leuk Lymphoma; 2014 Aug; 55(8):1768-73. PubMed ID: 24144314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survival.
    Nückel H; Frey UH; Sellmann L; Bau M; Dürig J; Dührsen U; Siffert W
    Leukemia; 2006 Apr; 20(4):724. PubMed ID: 16453002
    [No Abstract]   [Full Text] [Related]  

  • 47. Therapeutic approaches to chronic lymphocytic leukemia.
    Robertson LE; Keating MJ
    Tex Med; 1991 Nov; 87(11):68-74. PubMed ID: 1759245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is chronic lymphocytic leukemia one disease?
    Dighiero G
    Haematologica; 2002 Dec; 87(12):1233-5. PubMed ID: 12495892
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of the microenvironment in chronic lymphocytic leukaemia.
    Caligaris-Cappio F
    Br J Haematol; 2003 Nov; 123(3):380-8. PubMed ID: 14616995
    [No Abstract]   [Full Text] [Related]  

  • 50. Prognostic factors in chronic lymphocytic leukemia.
    Hallek M; Kuhn-Hallek I; Emmerich B
    Leukemia; 1997 Apr; 11 Suppl 2():S4-13. PubMed ID: 9178831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
    Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
    Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunophenotyping in leukaemias is not a luxury.
    Kurukulasuriya AP; Wijesiriwardene B; Perera TK
    Ceylon Med J; 1998 Jun; 43(2):117-8. PubMed ID: 9704557
    [No Abstract]   [Full Text] [Related]  

  • 53. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. International Workshop on Chronic Lymphocytic Leukemia.
    Ann Intern Med; 1989 Feb; 110(3):236-8. PubMed ID: 2912362
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical categories identified by a new prognostic index reflect biological characteristics of patients in early chronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL) experience.
    Molica S; Di Raimondo F; Cutrona G; Fabris S; Mauro F; Brugiatelli M; Baldini L; Musto P; Sacchi S; Cortelezzi A; Foà R; Neri A; Federico M; Ferrarini M; Morabito F;
    Leuk Res; 2010 Aug; 34(8):e217-8. PubMed ID: 20359746
    [No Abstract]   [Full Text] [Related]  

  • 55. Prognosis in chronic lymphocytic leukemia: let's have a look!
    Montserrat E
    Haematologica; 2002 Jun; 87(6):561-2. PubMed ID: 12031908
    [No Abstract]   [Full Text] [Related]  

  • 56. Prognosis in chronic lymphocytic leukemia (CLL): experience of the Italian cooperative group (GIMEMA).
    De Rossi G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():162-4. PubMed ID: 2653497
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronic lymphocytic leukemia and hairy-cell leukemia-diagnosis and treatment: results of a consensus meeting of the German CLL Co-operative Group.
    Brittinger G; Hellriegel KP; Hiddemann W
    Leukemia; 1997 Apr; 11 Suppl 2():S1-3. PubMed ID: 9178830
    [No Abstract]   [Full Text] [Related]  

  • 58. [Repertory of T lymphocytes in patients with stage A chronic lymphoid leukemia: revealed by monoclonal expansion of T cells in vivo].
    Farace F; Kremer F; Dietrich PY; Gaudin C; Angevin E; Courtier MH; Bayle C; Hercend T; Triebel F
    Bull Cancer; 1994 Oct; 81(10):897-9. PubMed ID: 7734775
    [No Abstract]   [Full Text] [Related]  

  • 59. Decision-tree approach to the immunophenotype-based prognosis of the B-cell chronic lymphocytic leukemia.
    Masić N; Gagro A; Rabatić S; Sabioncello A; Dasić G; Jaksić B; Vitale B
    Am J Hematol; 1998 Oct; 59(2):143-8. PubMed ID: 9766799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic and functional changes in chronic lymphocytic leukemia.
    Răileanu-Moţoiu I; Dumitrescu A
    Rom J Intern Med; 1993; 31(2):99-108. PubMed ID: 8268837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.